DE69328135D1 - Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren - Google Patents
Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzierenInfo
- Publication number
- DE69328135D1 DE69328135D1 DE69328135T DE69328135T DE69328135D1 DE 69328135 D1 DE69328135 D1 DE 69328135D1 DE 69328135 T DE69328135 T DE 69328135T DE 69328135 T DE69328135 T DE 69328135T DE 69328135 D1 DE69328135 D1 DE 69328135D1
- Authority
- DE
- Germany
- Prior art keywords
- rhesus
- produce
- cell lines
- human monoclonal
- monoclonal antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69328135T DE69328135D1 (de) | 1992-06-26 | 1993-06-22 | Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9207893A FR2692786B1 (fr) | 1992-06-26 | 1992-06-26 | Anticorps monoclonaux humains anti-rhesus d et lignees cellulaires les produisant. |
DE19924224357 DE4224357C2 (de) | 1992-07-23 | 1992-07-23 | Arzneimittel zur Prophylaxe von HDN, enthaltend menschliche monoclonale anti-Rhesus (D)-Antikörper |
DE69328135T DE69328135D1 (de) | 1992-06-26 | 1993-06-22 | Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69328135D1 true DE69328135D1 (de) | 2000-04-27 |
Family
ID=25916870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69328135T Expired - Lifetime DE69328135D1 (de) | 1992-06-26 | 1993-06-22 | Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren |
Country Status (12)
Country | Link |
---|---|
US (1) | US5851524A (de) |
EP (1) | EP0576093B1 (de) |
AT (1) | ATE191006T1 (de) |
AU (1) | AU678364B2 (de) |
BR (1) | BR9305557A (de) |
CA (1) | CA2116246A1 (de) |
DE (1) | DE69328135D1 (de) |
FI (1) | FI940811A (de) |
HU (1) | HUT68624A (de) |
MX (1) | MX9303839A (de) |
PL (1) | PL302438A1 (de) |
WO (1) | WO1994000561A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2807767B1 (fr) | 2000-04-12 | 2005-01-14 | Lab Francais Du Fractionnement | Anticorps monoclonaux anti-d |
FR2858235B1 (fr) | 2003-07-31 | 2006-02-17 | Lab Francais Du Fractionnement | Utilisation d'anticorps optimises en adcc pour traiter les patients faibles repondeurs |
FR2861078B1 (fr) * | 2003-10-16 | 2007-09-21 | Lab Francais Du Fractionnement | NOUVELLES IgG3 UTILES POUR STIMULER LA PHAGOCYTOSE |
EP1967529A1 (de) | 2004-07-20 | 2008-09-10 | Symphogen A/S | Rekombinanter polyklonaler Anti-Rhesus-D-Antikörper und Herstellungsverfahren |
ATE548657T1 (de) | 2004-07-20 | 2012-03-15 | Symphogen As | Prozedur zur strukturellen charakterisierung rekombinanter polyclonaler proteine oder einer polyclonalen zelllinie |
TWI391399B (zh) | 2005-05-25 | 2013-04-01 | Hoffmann La Roche | 測定溶離多肽之鹽濃度之方法 |
JP5064558B2 (ja) | 2007-06-01 | 2012-10-31 | エフ.ホフマン−ラ ロシュ アーゲー | 免疫グロブリン精製 |
CA2639003A1 (en) * | 2008-08-20 | 2010-02-20 | Canadian Blood Services | Inhibition of fc.gamma.r-mediated phagocytosis with reduced immunoglobulin preparations |
JP2012513425A (ja) | 2008-12-22 | 2012-06-14 | エフ.ホフマン−ラ ロシュ アーゲー | 免疫グロブリンの精製 |
US20110059079A1 (en) * | 2009-09-04 | 2011-03-10 | Xoma Technology Ltd. | Antibody Coformulations |
WO2011028961A2 (en) | 2009-09-04 | 2011-03-10 | Xoma Technology Ltd. | Anti-botulism antibody coformulations |
CN106267405B (zh) * | 2016-07-01 | 2019-02-19 | 翁炳焕 | 母胎血型不合溶血病治疗仪 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH652145A5 (de) * | 1982-01-22 | 1985-10-31 | Sandoz Ag | Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen. |
GB8722018D0 (en) * | 1987-09-18 | 1987-10-28 | Central Blood Lab Authority | Human anti-rh(d)monoclonal antibodies |
GB8722019D0 (en) * | 1987-09-18 | 1987-10-28 | Central Blood Lab Authority | Human anti-rh(d)monoclonal antibodies |
GB8722020D0 (en) * | 1987-09-18 | 1987-10-28 | Central Blood Lab Authority | Human anti-rh(d)monoclonal antibodies |
GB8906129D0 (en) * | 1989-03-17 | 1989-05-04 | Central Blood Lab Authority | Pharmaceutical preparations |
-
1993
- 1993-06-22 AU AU44197/93A patent/AU678364B2/en not_active Ceased
- 1993-06-22 EP EP93201797A patent/EP0576093B1/de not_active Expired - Lifetime
- 1993-06-22 WO PCT/EP1993/001591 patent/WO1994000561A1/en active Application Filing
- 1993-06-22 HU HU9400862A patent/HUT68624A/hu unknown
- 1993-06-22 DE DE69328135T patent/DE69328135D1/de not_active Expired - Lifetime
- 1993-06-22 BR BR9305557A patent/BR9305557A/pt not_active Application Discontinuation
- 1993-06-22 CA CA002116246A patent/CA2116246A1/en not_active Abandoned
- 1993-06-22 AT AT93201797T patent/ATE191006T1/de not_active IP Right Cessation
- 1993-06-22 PL PL93302438A patent/PL302438A1/xx unknown
- 1993-06-25 MX MX9303839A patent/MX9303839A/es not_active Application Discontinuation
-
1994
- 1994-02-21 FI FI940811A patent/FI940811A/fi unknown
-
1997
- 1997-02-10 US US08/798,444 patent/US5851524A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HU9400862D0 (en) | 1994-06-28 |
WO1994000561A1 (en) | 1994-01-06 |
CA2116246A1 (en) | 1994-01-06 |
FI940811A0 (fi) | 1994-02-21 |
AU4419793A (en) | 1994-01-24 |
EP0576093A1 (de) | 1993-12-29 |
US5851524A (en) | 1998-12-22 |
MX9303839A (es) | 1994-08-31 |
ATE191006T1 (de) | 2000-04-15 |
PL302438A1 (en) | 1994-07-25 |
EP0576093B1 (de) | 2000-03-22 |
HUT68624A (en) | 1995-07-28 |
BR9305557A (pt) | 1997-03-25 |
AU678364B2 (en) | 1997-05-29 |
FI940811A (fi) | 1994-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300433I2 (en) | Methods and compositions for the treatment of glomerulonephritis. | |
TR200002405T2 (tr) | İnsan CD40' a karşı antikorlar | |
ATE191006T1 (de) | Menschliche monoklonale antikörper gegen rhesus d und zellinien die diese produzieren | |
DE122004000036I1 (de) | Therapeutische Verwendung von chimerischen und markierten Antik¦rper gegen menschlichen B Lymphozyt beschr{nkter Differenzierung antigen f}r die Behandlung von B-Zell-Lymphoma. | |
TW376320B (en) | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma | |
DE69934515D1 (de) | Humanisierte monoklonale integrin antikörper | |
MXPA05014152A (es) | Anticuerpos dirigidos a los mutantes de delecion de receptor de factor de crecimiento epidermico y sus usos. | |
HK1008819A1 (en) | Piperidine derivatives as neurokinin antagonists | |
CY1112447T1 (el) | Ανθρωπινα αντισωματα για την ιντερλευκινη (ιντεrleukin) 15 (il-15) | |
MX9709238A (es) | Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales. | |
AU7690596A (en) | Anti-CD6 monoclonal antibodies and their uses | |
CY2198B1 (en) | 1-Aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists | |
SG48816A1 (en) | Gonococcal anti-idiotypic antibodies and methods and compositions using them | |
DE69007799D1 (de) | Pharmazeutische antigen-antikörper-komplexe enthaltende zusammensetzungen und deren anwendungen. | |
EP0493446A4 (en) | Treatment of autoimmune disease | |
EP0339163A3 (en) | Monoclonal antibodies specific for hiv and hybridomas for their production | |
DE59309133D1 (de) | Granulozytenbindende Antikörperkonstrukte, ihre Herstellung und Verwendung | |
CA2070182A1 (en) | Chimeric immunoglobulin for cd4 receptors | |
ATE254659T1 (de) | Mikroorganismen, ihre herstellung und verwendung | |
IT1254705B (it) | Anticorpi monoclonali specifici per il fattore neuronotrofico ciliare (cntf) umano ricombinante | |
GEP20043233B (en) | Composition Containing Blocking Monoclonal Antibody VLA-1 | |
HK1013296A1 (en) | Analogs of thymosin alpha 1 | |
AU6829396A (en) | Compositions and their uses | |
MX9710002A (es) | Nuevo uso medico. | |
MX9804579A (es) | Composiciones que contienen bismuto para la prevencion y tratamiento de trastornos gastrointestinales. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |